BriaCell Therapeutics Corp. (BCTX)
NASDAQ: BCTX · Real-Time Price · USD
0.561
-0.024 (-4.12%)
At close: Dec 20, 2024, 4:00 PM
0.580
+0.019 (3.39%)
After-hours: Dec 20, 2024, 7:28 PM EST
BriaCell Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is August - July.
Millions USD. Fiscal year is Aug - Jul.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '24 Dec 20, 2024 | Jul '24 Jul 31, 2024 | Jul '23 Jul 31, 2023 | Jul '22 Jul 31, 2022 | Jul '21 Jul 31, 2021 | Jul '20 Jul 31, 2020 |
| Market Capitalization | 26 | 14 | 106 | 101 | 79 | 5 | |
| Market Cap Growth | -56.06% | -87.19% | 4.90% | 29.07% | 1427.02% | -50.55% | |
| Enterprise Value | 20 | 12 | 77 | 57 | 59 | 5 | |
| Last Close Price | 0.56 | 0.75 | 6.69 | 6.50 | 5.08 | 7.20 | |
| PB Ratio | 8.03 | -5.08 | -28.18 | 9.82 | 2.84 | -1.43 | |
| P/TBV Ratio | 7.76 | - | - | 10.05 | 2.87 | - | |
| Debt / Equity Ratio | - | - | - | - | 0.00 | -0.11 | |
| Quick Ratio | 1.65 | 0.21 | 11.80 | 43.64 | 102.88 | 0.01 | |
| Current Ratio | 1.65 | 0.49 | 14.96 | 45.00 | 103.81 | 0.07 | |
| Return on Equity (ROE) | -536.81% | - | -619.75% | -141.25% | -114.78% | - | |
| Return on Assets (ROA) | -129.07% | -126.11% | -41.71% | -18.99% | -14.89% | -509.24% | |
| Return on Capital (ROIC) | -601.59% | - | -444.01% | -50.26% | -35.58% | - | |
| Earnings Yield | -65.01% | -35.14% | -19.08% | -26.45% | -17.58% | -78.18% | |
| FCF Yield | -93.75% | -180.30% | -22.31% | -12.30% | -9.86% | -24.59% | |
| Buyback Yield / Dilution | -21.51% | -5.35% | -0.81% | -242.82% | -533.09% | -23.16% | |
| Total Shareholder Return | -21.51% | -5.35% | -0.81% | -242.82% | -533.09% | -23.16% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.